国药控股(01099)披露2026年中期业绩:营收2,827.99亿元,同比微降1.13%

公告速递
Aug 24

国药控股股份有限公司(01099)于2026年8月21日公布截至2026年6月30日止六个月未经审计的中期业绩。期内,公司实现收入2,827.99亿元,较上年同期的2,860.43亿元减少1.13%;实现溢利51.80亿元,同比下降2.95%;归属于母公司持有者的溢利34.04亿元,同比下降1.79%。基本每股收益为人民币1.09元,较上年同期的1.11元减少0.02元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10